Pharmacochaperones Post-translationally Enhance Cell Surface Expression by Increasing Conformational Stability of Wild-type and Mutant Vasopressin V2 Receptors
Some membrane-permeable antagonists restore cell surface expression of misfolded receptors retained in the endoplasmic reticulum (ER) and are therefore termed pharmacochaperones. Whether pharmacochaperones increase protein stability, thereby preventing rapid degradation, or assist folding via direct...
Saved in:
Published in | The Journal of biological chemistry Vol. 279; no. 45; pp. 47254 - 47263 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Biochemistry and Molecular Biology
05.11.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Some membrane-permeable antagonists restore cell surface expression of misfolded receptors retained in the endoplasmic reticulum
(ER) and are therefore termed pharmacochaperones. Whether pharmacochaperones increase protein stability, thereby preventing
rapid degradation, or assist folding via direct receptor interactions or interfere with quality control components remains
elusive. We now show that the cell surface expression and function (binding of the agonist) of the mainly ER-retained wild-type
murine vasopressin V 2 receptor GFP fusion protein (mV 2 R·GFP) is restored by the vasopressin receptor antagonists SR49059 and SR121463B with EC 50 values similar to their K D values. This effect was preserved when protein synthesis was abolished. In addition, SR121463B rescued eight mutant human
V 2 Rs (hV 2 Rs, three are responsible for nephrogenic diabetes insipidus) characterized by amino acid exchanges at the C-terminal end
of transmembrane helix TM I and TM VII. In contrast, mutants with amino acid exchanges at the interface of TM II and IV were
not rescued by either antagonist. The mechanisms involved in successful rescue of cell surface delivery are explained in a
three-dimensional homology model of the antagonist-bound hV 2 R. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M408154200 |